Characterization of uropathogenic ESBL-producing Escherichia coli isolated from hospitalized patients in western Algeria.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
30 04 2019
Historique:
received: 24 07 2018
accepted: 16 11 2018
entrez: 12 2 2020
pubmed: 12 2 2020
medline: 10 7 2020
Statut: epublish

Résumé

The aim of this study is to assess the prevalence and molecular characterization of uropathogenic Extended spectrum β-lactamases (ESBLs) producing Escherichia coli. During 3 years, all hospitalized patients at the University-affiliated hospital of Tlemcen and presenting urinary tract infections caused by E. coli were considered as potential study participants. These E. coli isolates were examined phenotypically for ESBL production. ESBL strains were subjected to antimicrobial susceptibility testing and were investigated for the presence of plasmid mediated quinolone resistance genes, 16SrRNA methylase genes and virulence genes by using conventional PCR and DNA sequencing. The molecular characterization of ESBL strains was established by phylogenetic grouping method and ERIC-PCR. The overall prevalence of ESBL was 32.5%. The blaCTX-M-15 was the most frequently detected in ESBL isolates, followed by blaCTX-M-14, blaCTX-M-28, blaCTX-M-1 and blaSHV-12 respectively. The plasmid-mediated quinolone resistance genes were detected in the 15 ESBL strains with the aac(6')-Ib-cr gene was the most detected followed by qnrB1 and qnrA1 gene respectively. Among the 22 ESBL isolates resistant to gentamicin and amikacin, the 16SrRNA methylase genes were detected in 4 isolates. The sfa and pap virulent genes were founds in 26% and 22% of isolates receptively. The genotyping analysis of all strains revealed that almost were belonged to phylogenetic groups A1 and A0 and fourteen distinct clones. The emergence of uropathogenic ESBL isolates and the high rate of blaCTX-M are alarming in Algeria. Strict measure must be required to control the further spread of these strains in Algerian hospitals.

Identifiants

pubmed: 32045373
doi: 10.3855/jidc.10702
doi:

Substances chimiques

Escherichia coli Proteins 0
Virulence Factors 0
Methyltransferases EC 2.1.1.-
rRNA (adenosine-O-2'-)methyltransferase EC 2.1.1.230
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

291-302

Informations de copyright

Copyright (c) 2019 Mohammed Timinouni, Abouddihaj Barguigua, Fethi Benbelaïd, Kaotar Nayme, Fatima Zenati, Abdelmounaïm Khadir, Chafika Bellahsene, Mourad Bendahou, Hassaïne Hafida.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Fatima Zenati (F)

Laboratory of Applied Microbiology in Food, Biomedical and Environment, Aboubekr Belkaïd University, Tlemcen, Algeria. zenatifatima_2013@yahoo.fr.

Abouddihaj Barguigua (A)

Laboratory of Biotechnology and Sustainable Development of Natural Resources, Polydisciplinary Faculty, Sultan Moulay Slimane University, Beni Mellal, Morocco. dihaj82@yahoo.fr.

Kaotar Nayme (K)

Molecular Bacteriology Laboratory, Pasteur Institute of Morocco, Casablanca, Morocco. kaotar.nayme@pasteur.ma.

Fethi Benbelaïd (F)

Laboratory of Applied Microbiology in Food, Biomedical and Environment, Aboubekr Belkaïd University, Tlemcen, Algeria. zino.fethi@gmail.com.

Abdelmounaïm Khadir (A)

Laboratory of Applied Microbiology in Food, Biomedical and Environment, Aboubekr Belkaïd University, Tlemcen, Algeria. khadirabdel1@yahoo.fr.

Chafika Bellahsene (C)

Laboratory of Applied Microbiology in Food, Biomedical and Environment, Aboubekr Belkaïd University, Tlemcen, Algeria. b_ch_2008@hotmail.com.

Mourad Bendahou (M)

Laboratory of Applied Microbiology in Food, Biomedical and Environment, Aboubekr Belkaïd University, Tlemcen, Algeria. bendahoumourad9@gmail.com.

Hassaïne Hafida (H)

Laboratory of Applied Microbiology in Food, Biomedical and Environment, Aboubekr Belkaïd University, Tlemcen, Algeria. h_hassaine@yahoo.fr.

Mohammed Timinouni (M)

Laboratory of Applied Microbiology in Food, Biomedical and Environment, Aboubekr Belkaïd University, Tlemcen, Algeria. mohammed.timinouni@pasteur.ma.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH